Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
about
Multi-omics approach to study the growth efficiency and amino acid metabolism in Lactococcus lactis at various specific growth ratesProtective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase.Engineering trehalose synthesis in Lactococcus lactis for improved stress tolerance.Evaluation of oral immunization with recombinant avian influenza virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin subunit B.Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.Recombinant Lactococcus lactis expressing porcine insulin-like growth factor I ameliorates DSS-induced colitis in miceA new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces.Engineering commensal bacteria for prophylaxis against infection.Construction of a recombinant allergen-producing probiotic bacterial strain: Introduction of a new line for a live oral vaccine against Chenopodium album pollen allergyRole of commensal and probiotic bacteria in human health: a focus on inflammatory bowel diseaseInduction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.Perspectives for the development of human papillomavirus vaccines and immunotherapy.Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?Potential role of probiotics in the management of gastric ulcer.Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model.Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials.Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice.Lactococcus lactis : A New Strategy for Vaccination.Live Bacterial Vectors-A Promising DNA Vaccine Delivery System.Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* proteinMicroencapsulation of Lactic Acid Bacteria Improves the Gastrointestinal Delivery and Expression of Recombinant Fluorescent ProteinRotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine modelGenome alterations associated with improved transformation efficiency in Lactobacillus reuteri
P2860
Q21246034-ABC33FA3-A809-4A25-9718-41E8965FDE84Q30373761-C456594D-A117-4D6A-A860-553FF735CAB0Q30502263-4FACD95A-F560-435B-AE1E-31CBE56EC840Q35138652-230F797E-A1F9-4A65-9081-8BBB85665A9DQ35142923-9DC816EE-62BD-41D5-BD43-8BAEA47ACA37Q35596025-001A5BAF-6779-402B-BEE1-EEFBF67614E5Q35858585-E2D0B3E0-6252-4580-BC08-0378A91CF17BQ35942422-480ED3B8-AE27-4763-94BE-11395FD6D45BQ36020625-B72425F7-9395-4BFA-B26B-86388DEC9A19Q36074828-6C53C1DB-E017-4A72-908E-423041AEB79BQ36589520-BCA1A722-C85B-44F9-8FD9-1E0669575C70Q37053638-D25E9FC1-A672-4DDF-AA4B-103FDFE126A8Q37248099-5F14217D-A35E-4F06-ABAD-DAEC274D14B1Q37658876-A94977A9-D4C1-4940-905C-33A01356CC5AQ37825908-7C39F1C1-B9B7-4A0A-93E7-8E8028C766B9Q38253241-4E38A347-A79B-494A-965C-F0145FAC7CD2Q38848225-B349473B-5E35-4A1A-ABA2-3683A06A7E6DQ39780890-EE2B5C32-AF86-4E63-AA3F-9C9039DA6B4AQ40283850-57DB63CB-C63A-4956-8FAC-5B393818F143Q40701445-A8B55092-A766-4B1F-86C5-0E2C80003E2EQ45883861-5EC8C183-25E4-443E-AC26-9C5E10924283Q47150132-35B43BE3-7284-4EBE-B928-41984ACDBDF2Q52640510-DA660F56-862E-4260-87B8-A9FE56F5D5D4Q57223797-2497793B-8316-4B88-8A92-40EF069E1C83Q57817954-914917D1-2DA7-4F5C-9EB1-A8168AEEC99BQ58759991-7C475636-0F95-4521-9D27-B8CDA4B0D81DQ58768723-5EF93409-438D-4CBB-968E-9F1FFBCE55A9
P2860
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@en
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@nl
type
label
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@en
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@nl
prefLabel
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@en
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@nl
P356
P1433
P1476
Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
@en
P2093
Luis G Bermúdez-Humarán
P304
P356
10.4161/HV.5.4.7553
P577
2009-04-30T00:00:00Z